PIK3CB/p110β is a selective survival factor for glioblastoma

BACKGROUND: Glioblastoma (GBM) is difficult to treat. Phosphoinositide 3-kinase (PI3K) is an attractive therapeutic target for GBM; however, targeting this pathway to effectively treat GBM is not successful because the roles of PI3K isoforms remain to be defined. The aim of this study is to determin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Pridham, Kevin J, Le, Lamvy, Guo, Sujuan, Varghese, Robin T, Algino, Sarah, Liang, Yanping, Fajardin, Renee, Rodgers, Cara M, Simonds, Gary R, Kelly, Deborah F, Sheng, Zhi
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Basic and Translational Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909664/
https://ncbi.nlm.nih.gov/pubmed/29016844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox181
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados